Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ZAFIRA®

K-Number: K254245 · 2026-03-03

Decision Date2026-03-03
Product CodeEBF
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

ZAFIRA® is the device name listed in this FDA 510(k) record. The listed applicant is New Stetic, SA. It received FDA 510(k) clearance on 2026-03-03 under 510(k) number K254245. The device is classified under product code EBF. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ZAFIRA®?

ZAFIRA® is a medical device that received FDA 510(k) clearance on 2026-03-03. The listed applicant is New Stetic, SA. The 510(k) number is K254245.

When did ZAFIRA® receive FDA 510(k) clearance?

ZAFIRA® received FDA 510(k) clearance on 2026-03-03, under 510(k) number K254245.

Who is the listed applicant for ZAFIRA®?

The FDA 510(k) record lists New Stetic, SA as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ZAFIRA®?

The FDA product code for ZAFIRA® is EBF.

Other records listing New Stetic, SA as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: EBF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.